Disentangling Substance Use and Psychiatric Disorder Comorbidity for Future HuGE

解开未来 HuGE 的药物使用和精神疾病合并症

基本信息

  • 批准号:
    7046288
  • 负责人:
  • 金额:
    $ 22.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-30 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): There is a rapidly increasing need of public health significance to integrate human genetic information into analyses of population epidemiologic data to provide better understanding of biology-environment mechanisms underlying comorbidity of substance use and psychiatric disorders. In response to RFA-DA- 05-005, this R01 application requests support for 5 years to conduct coordinated analyses of NLAES, NESARC, Add Health and NHSDA/NSDUH repeated cross-sectional and/or longitudinal adolescent and adult national survey datafiles (each with different strengths and weaknesses) to provide informative results for future human-genome epidemiology (HuGE) aspects of NESARC. Race/ethnicity, immigration and acculturation, and family history, as well as gender, are conceptualized as key "low-resolution" genetic-behavioral-social (G-B-S) markers (reflecting molecular evolutionary history and recent population dynamics) to capture the interplay of genetic and environmental etiological factors. The main phenotypes are cross-sectional or longitudinal comorbidity of relatively-common substance use and psychiatric disorders or syndromes; the pleiotropy concept is applied to unrelated individuals. Add Health data with limited candidate gene information will be used to guide analyses for NESARC; when genotype information becomes available from NESARC, a portion of the phenotypic variance across race/ethnicity and individuals should be "explained away" by candidate gene main effects, epistasis, gene -environment interactions, in addition to independent environmental effects already measurable from the current NESARC datafiles. Specific analysis aims are to: 1) select phenotypes suitable for multiple-phenotype analyses by examining race/ethnicity differences on the comorbidity of two disorders that identify phenotypes that are likely to be influenced by relatively new polymorphisms or by relatively localized environmental factors or both; 2) corroborate cross-sectional phenotype selection achieved in Aim 1 from a genetic perspective; 3) delineate major gender- and race-/ethnic-specific environmental influences on the phenotypes selected in Aim 1; 4) improve polygenic measures standing-in for candidate genes for use in Aims 6), 7) and 8); 5) develop pleiotropy models of substance use abuse and psychiatric comorbidity (SAPC) to guide Aims 6), 7), and 8); 6) develop and test cross-sectional pleiotropy models for NESARC including environmental measures identified in Aim 3); 7) develop longitudinal pleiotropy models of SAPC for NESARC; 8) replicate the pleiotropy models developed in Aims 6) and 7) by replacing stand-in polygenic measures with candidate genotypes, pending on the availability of genotype data from NESARC.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RUMI KATO PRICE其他文献

RUMI KATO PRICE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RUMI KATO PRICE', 18)}}的其他基金

Disentangling Substance Use and Psychiatric Disorder Comorbidity for Future HuGE
解开未来 HuGE 的药物使用和精神疾病合并症
  • 批准号:
    7500010
  • 财政年份:
    2005
  • 资助金额:
    $ 22.95万
  • 项目类别:
Disentangling Substance Use and Psychiatric Disorder Comorbidity for Future HuGE
解开未来 HuGE 的药物使用和精神疾病合并症
  • 批准号:
    7498392
  • 财政年份:
    2005
  • 资助金额:
    $ 22.95万
  • 项目类别:
Disentangling Substance Use and Psychiatric Disorder Comorbidity for Future HuGE
解开未来 HuGE 的药物使用和精神疾病合并症
  • 批准号:
    7280368
  • 财政年份:
    2005
  • 资助金额:
    $ 22.95万
  • 项目类别:
Disentangling Substance Use and Psychiatric Disorder Comorbidity for Future HuGE
解开未来 HuGE 的药物使用和精神疾病合并症
  • 批准号:
    7673472
  • 财政年份:
    2005
  • 资助金额:
    $ 22.95万
  • 项目类别:
Disentangling Substance Use and Psychiatric Disorder Comorbidity for Future HuGE
解开未来 HuGE 的药物使用和精神疾病合并症
  • 批准号:
    7126368
  • 财政年份:
    2005
  • 资助金额:
    $ 22.95万
  • 项目类别:
Follow-Up of Vietnam Veterans at Risk for Suicide
对有自杀风险的越南退伍军人的后续行动
  • 批准号:
    6583184
  • 财政年份:
    2001
  • 资助金额:
    $ 22.95万
  • 项目类别:
Follow-Up of Vietnam Veterans at Risk for Suicide
对有自杀风险的越南退伍军人的后续行动
  • 批准号:
    6398163
  • 财政年份:
    2001
  • 资助金额:
    $ 22.95万
  • 项目类别:
Follow-Up of Vietnam Veterans at Risk for Suicide
对有自杀风险的越南退伍军人的后续行动
  • 批准号:
    6528643
  • 财政年份:
    2001
  • 资助金额:
    $ 22.95万
  • 项目类别:
Follow-Up of Vietnam Veterans at Risk for Suicide
对有自杀风险的越南退伍军人的后续行动
  • 批准号:
    6653098
  • 财政年份:
    2001
  • 资助金额:
    $ 22.95万
  • 项目类别:
Follow-Up of Vietnam Veterans at Risk for Suicide
对有自杀风险的越南退伍军人的后续行动
  • 批准号:
    6796276
  • 财政年份:
    2001
  • 资助金额:
    $ 22.95万
  • 项目类别:

相似国自然基金

Substance P调控表皮δγT细胞分泌NGF促进创面愈合的作用和机制研究
  • 批准号:
    81571904
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
神经肽Substance P调控HSV-1在三叉神经节内潜伏复发的分子机制研究
  • 批准号:
    81570820
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目

相似海外基金

Family processes underlying adolescent substance use and conduct problems: disentangling correlation and causation
青少年物质使用和行为问题背后的家庭过程:理清相关性和因果关系
  • 批准号:
    10577848
  • 财政年份:
    2022
  • 资助金额:
    $ 22.95万
  • 项目类别:
Family processes underlying adolescent substance use and conduct problems: disentangling correlation and causation
青少年物质使用和行为问题背后的家庭过程:理清相关性和因果关系
  • 批准号:
    10427677
  • 财政年份:
    2022
  • 资助金额:
    $ 22.95万
  • 项目类别:
Adolescent substance use as determinant and consequence of the school-to-prison pipeline: Disentangling individual risk, social determinants, and group disparities
青少年药物使用作为学校到监狱渠道的决定因素和后果:理清个人风险、社会决定因素和群体差异
  • 批准号:
    10331308
  • 财政年份:
    2019
  • 资助金额:
    $ 22.95万
  • 项目类别:
Adolescent substance use as determinant and consequence of the school-to-prison pipeline: Disentangling individual risk, social determinants, and group disparities
青少年药物使用作为学校到监狱渠道的决定因素和后果:理清个人风险、社会决定因素和群体差异
  • 批准号:
    10554323
  • 财政年份:
    2019
  • 资助金额:
    $ 22.95万
  • 项目类别:
Adolescent Substance Use Initiation: Disentangling neurocognitive risks from consequences using longitudinal and genetically-informed methods
青少年药物使用启动:使用纵向和遗传信息方法将神经认知风险与后果分开
  • 批准号:
    10591235
  • 财政年份:
    2015
  • 资助金额:
    $ 22.95万
  • 项目类别:
Sibling effects on substance use: Disentangling genetic and environmental factors
兄弟姐妹对物质使用的影响:理清遗传和环境因素
  • 批准号:
    8835991
  • 财政年份:
    2014
  • 资助金额:
    $ 22.95万
  • 项目类别:
Sibling effects on substance use: Disentangling genetic and environmental factors
兄弟姐妹对物质使用的影响:理清遗传和环境因素
  • 批准号:
    8933938
  • 财政年份:
    2014
  • 资助金额:
    $ 22.95万
  • 项目类别:
Disentangling Substance Use and Psychiatric Disorder Comorbidity for Future HuGE
解开未来 HuGE 的药物使用和精神疾病合并症
  • 批准号:
    7500010
  • 财政年份:
    2005
  • 资助金额:
    $ 22.95万
  • 项目类别:
Disentangling Substance Use and Psychiatric Disorder Comorbidity for Future HuGE
解开未来 HuGE 的药物使用和精神疾病合并症
  • 批准号:
    7498392
  • 财政年份:
    2005
  • 资助金额:
    $ 22.95万
  • 项目类别:
Disentangling Substance Use and Psychiatric Disorder Comorbidity for Future HuGE
解开未来 HuGE 的药物使用和精神疾病合并症
  • 批准号:
    7280368
  • 财政年份:
    2005
  • 资助金额:
    $ 22.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了